Middle East & Africa Companion Animal Healthcare Market, by Therapeutics, 2018-2027

Growth Outlook

• The 2027 portion of the Middle East & Africa Companion Animal Healthcare Market, by Therapeutics, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 3954 Mn in 2026 and is projected to reach USD 4332 Mn by 2027 — a gain of about 10% over the forecast period, translating to a CAGR in the high single digits.
• What the regional split looks like (2026): Pharmaceuticals leads, holding roughly 58% of segment value — the single largest regional share. Vaccines is the second-largest contributor. Feed Additives make up the remainder, in descending order.
• By 2027, Pharmaceuticals alone is expected to reach USD 2486 Mn, with Vaccines at USD 943 Mn.

Market Dynamics

The demand for companion animal healthcare services in the Middle East and Africa region is on the rise, driven by a growing pet population and an increasing awareness about pet health and wellness. According to market reports, the Middle East & Africa Companion Animal Healthcare Market is expected to witness significant growth in the coming years, with a compound annual growth rate of over 6%.

Therapeutics is a major segment of the companion animal healthcare market, encompassing products and services used for the treatment of various diseases and conditions in companion animals. The demand for therapeutics in the Middle East and Africa region is being fueled by a number of factors, including a rise in pet ownership, an increase in the prevalence of chronic diseases among companion animals, and the availability of advanced treatment options.

One of the key drivers of the demand for therapeutics in the Middle East and Africa region is the growing popularity of pets as companions. In recent years, there has been a significant increase in the number of households keeping pets in the region. This trend is expected to continue in the coming years, due to factors such as rising disposable income, urbanization, and changing lifestyles. As more individuals consider pets as integral parts of their families, the demand for high-quality healthcare services for their companions is also increasing.

Moreover, the increasing prevalence of chronic diseases among companion animals is also contributing to the demand for therapeutics. This can be attributed to factors such as a lack of proper nutrition and a sedentary lifestyle, which can lead to conditions such as obesity, diabetes, and heart diseases in pets. As a result, there is a growing need for effective therapeutic options to treat and manage these diseases.

The availability of advanced treatment options in the Middle East and Africa region is also a key factor driving the demand for therapeutics. With advancements in technology and the development of new and improved medications, there are now more options available for the treatment of various diseases in companion animals. This has led to an increase in demand for these services, as pet owners are willing to spend more on their beloved companions' healthcare.

In conclusion, the demand for therapeutics in the Middle East and Africa Companion Animal Healthcare Market is expected to continue its upward trend in the coming years. With a growing pet population, an increasing prevalence of chronic diseases, and the availability of advanced treatment options, the demand for these services is likely to remain strong in the region.